Cargando…

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

PURPOSE: Apolipoproteins C-I, C-II, C-III and E have been associated with risk of arterial thrombotic diseases. We investigated whether these apolipoproteins have prothrombotic properties and are associated with risk of venous thromboembolism (VTE). PATIENTS AND METHODS: A total of 127 VTE patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orsi, Fernanda A, Lijfering, Willem M, Van der Laarse, Arnoud, Ruhaak, L Renee, Rosendaal, Frits R, Cannegieter, Suzanne C, Cobbaert, Christa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659780/ https://www.ncbi.nlm.nih.gov/pubmed/31413640 http://dx.doi.org/10.2147/CLEP.S196266

Ejemplares similares

Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
por: Renee Ruhaak, L, et al.
Publicado: (2019)

Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study
por: Orsi, Fernanda A., et al.
Publicado: (2021)

Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up
por: Bodde, Mathijs C., et al.
Publicado: (2018)

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism
por: Nemeth, Banne, et al.
Publicado: (2019)

Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study
por: Yap, Eng Soo, et al.
Publicado: (2023)

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
por: Orsi, Fernanda A., et al.
Publicado: (2019)

Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trial
por: Camilleri, Eleonora, et al.
Publicado: (2023)

Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Lipid levels and risk of venous thrombosis: results from the MEGA-study
por: Morelli, Vânia M., et al.
Publicado: (2017)

The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk
por: Khialani, Deeksha, et al.
Publicado: (2020)

Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case‐control study
por: Li‐Gao, Ruifang, et al.
Publicado: (2018)

Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study
por: Yap, Eng Soo, et al.
Publicado: (2023)

Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism
por: Scheres, Luuk J.J., et al.
Publicado: (2020)

Nutrition and venous thrombosis: An exercise in thinking about survivor bias
por: Lijfering, Willem M., et al.
Publicado: (2018)

Factor V levels and risk of venous thrombosis: The MEGA case‐control study
por: Rietveld, Inge M., et al.
Publicado: (2018)

Bloodcurdling movies and measures of coagulation: Fear Factor crossover trial
por: Nemeth, Banne, et al.
Publicado: (2015)

Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study
por: Bordbar, Mohammadreza, et al.
Publicado: (2021)

Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
por: Timp, Jasmijn F., et al.
Publicado: (2021)

Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study
por: Brækkan, Sigrid K., et al.
Publicado: (2017)

Endogenous sex hormones and risk of venous thromboembolism in young women
por: Scheres, Luuk J. J., et al.
Publicado: (2019)

The role of dyslipidemia and statins in venous thromboembolism
por: Ray, Joel G, et al.
Publicado: (2001)

Predicting the risk of recurrent venous thrombosis: What the future might bring
por: Lijfering, Willem M., et al.
Publicado: (2019)

Current and future burden of venous thrombosis: Not simply predictable
por: Scheres, Luuk J. J., et al.
Publicado: (2018)

Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort
por: Paulsen, Benedikte, et al.
Publicado: (2021)

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort
por: Gade, Inger Lise, et al.
Publicado: (2018)

Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors
por: Flinterman, Linda E., et al.
Publicado: (2012)

Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study
por: Rokx, Casper, et al.
Publicado: (2020)

Association between cardiovascular risk factors and venous thromboembolism in the elderly
por: Wang, Huijie, et al.
Publicado: (2022)

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
por: Scheres, Luuk J. J., et al.
Publicado: (2018)

Travel-Related Venous Thrombosis: Results from a Large Population-Based Case Control Study (MEGA Study)
por: Cannegieter, Suzanne C, et al.
Publicado: (2006)

Antithrombin diagnostics by mass spectrometry: Development and analytical validation of a next-generation test
por: Kruijt, Mirjam, et al.
Publicado: (2023)

The Absolute Risk of Venous Thrombosis after Air Travel: A Cohort Study of 8,755 Employees of International Organisations
por: Kuipers, Saskia, et al.
Publicado: (2007)

C-reactive protein, immunothrombosis and venous thromboembolism
por: Dix, Caroline, et al.
Publicado: (2022)

Microbial Modulation of Coagulation Disorders in Venous Thromboembolism
por: Lichota, Anna, et al.
Publicado: (2020)

Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer
por: Wang, Min, et al.
Publicado: (2019)

Inflammatory Cytokines as Risk Factors for a First Venous Thrombosis: A Prospective Population-Based Study
por: Christiansen, Sverre C, et al.
Publicado: (2006)

Sex‐specific aspects of venous thromboembolism: What is new and what is next?
por: Scheres, Luuk J. J., et al.
Publicado: (2022)

Risk of cancer in patients with thyroid disease and venous thromboembolism
por: Christensen, Diana H, et al.
Publicado: (2018)

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
por: Chen, Wei-Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iun1lo6mvkrsci39rteidqmr8f